MannKind Corp (MNKD):企業の財務・戦略的SWOT分析

◆英語タイトル:MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH44250FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MannKind Corp (MNKD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a rapid-action inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It consists of a dry powder formulation of human insulin delivered from small and portable inhaler. The company develops products based on its proprietary Technosphere formulation technology. The company has manufacturing facility in Danbury, Connecticut and sells product to wholesale distributors and specialty pharmacies in the US. MannKind is headquartered in Westlake Village, California, the US.

MannKind Corp Key Recent Developments

Mar 10,2021: MannKind Corporation to Participate in Oppenheimer’s 31st Annual Healthcare Conference
Feb 25,2021: MannKind reports 2020 fourth quarter and full year financial results
Feb 18,2021: MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
Dec 10,2020: James S. Shannon transitions to chairman of the board of directors for MannKind
Dec 01,2020: MannKind and MidCap amend credit facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MannKind Corp – Key Facts
MannKind Corp – Key Employees
MannKind Corp – Key Employee Biographies
MannKind Corp – Major Products and Services
MannKind Corp – History
MannKind Corp – Company Statement
MannKind Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MannKind Corp – Business Description
Business Segment: Collaborations and Services
Overview
Performance
Business Segment: Commercial Product Sales
Overview
Performance
R&D Overview
MannKind Corp – Corporate Strategy
MannKind Corp – SWOT Analysis
SWOT Analysis – Overview
MannKind Corp – Strengths
MannKind Corp – Weaknesses
MannKind Corp – Opportunities
MannKind Corp – Threats
MannKind Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MannKind Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2021: MannKind Corporation to Participate in Oppenheimer’s 31st Annual Healthcare Conference
Feb 25, 2021: MannKind reports 2020 fourth quarter and full year financial results
Feb 18, 2021: MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
Dec 10, 2020: James S. Shannon transitions to chairman of the board of directors for MannKind
Dec 01, 2020: MannKind and MidCap amend credit facility
Nov 30, 2020: Sabrina Kay appointed to MannKind Board of Directors
Nov 04, 2020: MannKind reports 2020 third quarter financial results
Aug 31, 2020: Kevin Kaiserman joins MannKind as Vice President, Medical Affairs and Safety
Aug 05, 2020: MannKind reports 2020 second quarter financial results
Jul 20, 2020: Alejandro Galindo joins MannKind as Chief Commercial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MannKind Corp, Key Facts
MannKind Corp, Key Employees
MannKind Corp, Key Employee Biographies
MannKind Corp, Major Products and Services
MannKind Corp, History
MannKind Corp, Other Locations
MannKind Corp, Subsidiaries
MannKind Corp, Key Competitors
MannKind Corp, Ratios based on current share price
MannKind Corp, Annual Ratios
MannKind Corp, Annual Ratios (Cont...1)
MannKind Corp, Annual Ratios (Cont...2)
MannKind Corp, Interim Ratios
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MannKind Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MannKind Corp (MNKD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boeing Defence Australia Limited:企業の戦略・SWOT・財務情報
    Boeing Defence Australia Limited - Strategy, SWOT and Corporate Finance Report Summary Boeing Defence Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Senex Energy Ltd (SXY):企業の財務・戦略的SWOT分析
    Summary Senex Energy Ltd (Senex) is an independent upstream oil and gas company. It mainly focuses on the east coast of Australia. The company acquires, explores, and develops oil and gas assets in the Surat and Cooper basins. It owns significant acreage in the basins with operatorship over all of i …
  • Geron Corp (GERN)-製薬・医療分野:企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pi …
  • Fluent Inc (FLNT):企業の財務・戦略的SWOT分析
    Fluent Inc (FLNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Memphasys Ltd (MEM)-医療機器分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • West Fraser Timber Co. Ltd. (WFT):企業の財務・戦略的SWOT分析
    West Fraser Timber Co. Ltd. (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CMA CGM SA:戦略・SWOT・企業財務分析
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Covea Insurance plc:企業の戦略・SWOT・財務情報
    Covea Insurance plc - Strategy, SWOT and Corporate Finance Report Summary Covea Insurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Michael Kors Holdings Ltd:企業の戦略・SWOT・財務情報
    Michael Kors Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Michael Kors Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hecla Mining Company:企業のM&A・事業提携・投資動向
    Hecla Mining Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hecla Mining Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Dompe Farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Dompe Farmaceutici SpA (Dompe) is a developer of therapeutic solutions that research novel therapies for the treatment of rare and orphan diseases. The company provides product pipeline such as C5aR Antagonists, TRPM8 Blockers pain, TRPM8 Blockers urology, BKB1R Antagonists, CNR2 Agonists an …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • SLM Corp:企業の戦略・SWOT・財務情報
    SLM Corp - Strategy, SWOT and Corporate Finance Report Summary SLM Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Coeur Mining Inc:企業の戦略・SWOT・財務分析
    Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Consumers Energy Company:発電所・企業SWOT分析
    Consumers Energy Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Royal College of Surgeons Ireland:製薬・医療:M&Aディール及び事業提携情報
    Summary Royal College of Surgeons Ireland (RCSI) is an educational institution that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The institute provides undergraduate courses in nursing, postgraduate research, leadership courses, and surgic …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆